Author: Jenny Lu

GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has closed its oversubscribed seed round at $1.77 million, with key investors TYDO and TELUS Ventures. Following early commercial success in Canada, this financing supports GenXys plans...

Great attendance with many opportunities to connect with clients and partners. Thank you for visiting our booth to learn more about how precision prescribing software is transforming healthcare delivery making patient-centered care front and center. Traversing innovative technologies to enable the translation of precision medicine into the clinic Precision...

TreatGx is an evidence-based medication decision support system that provides personalized prescribing options for the management of common conditions. TreatGx logic trees include: 1. status of the condition being treated 2. previous non-pharmacological and pharmacological treatment(s) 3. current non-pharmacological and pharmacological treatment(s) 4. other diagnoses 5. pharmacogenetics 6. renal and hepatic function 7....